Literature DB >> 19820615

No pain, but no gain? The disappearance of angina hospitalizations, 1992-1999.

Barry G Saver1, Sharon A Dobie, Pamela K Green, Ching-Yun Wang, Laura-Mae Baldwin.   

Abstract

BACKGROUND: Hospitalization for angina is commonly considered an ambulatory care sensitive hospitalization and used as a measure of access to primary care.
OBJECTIVE: To analyze time trends in angina-related hospitalizations and seek possible explanations for an observed, marked decline during 1992 to 1999. RESEARCH
DESIGN: We analyzed Medicare claims of SEER-Medicare control subjects for occurrence of angina hospital discharges, using the Agency for Healthcare Research and Quality Prevention Quality Indicator (PQI) definition, along with occurrence of related events including angina admissions with revascularization, angina admissions discharged as coronary artery disease (CAD) or myocardial infarction, and overall ischemic heart disease discharges.
SUBJECTS: Approximately 124,000 cancer-free Medicare beneficiary/ies, with subjects contributing data for 1 to 8 years.
RESULTS: Angina PQI hospital discharges declined 75% between 1992 and 1999. CAD hospital discharges rose in a reciprocal pattern, while angina discharges with revascularization declined and discharges for myocardial infarction and ischemic heart disease were relatively constant during this time period.
CONCLUSIONS: The marked decline in angina PQI hospital discharges during 1992-1999 does not appear to represent improvements in access to care or prevention of heart disease, but rather increased coding of more specific discharge diagnoses for CAD. Our findings suggest that angina hospitalization is not a valid measure for monitoring access to care and, more generally, demonstrate the need for careful, periodic re-evaluation of quality measures.

Entities:  

Mesh:

Year:  2009        PMID: 19820615      PMCID: PMC2761607          DOI: 10.1097/MLR.0b013e31819e1f53

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

1.  Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks.

Authors:  Sharon K Davis; Yong Liu; Gary H Gibbons
Journal:  Am J Public Health       Date:  2003-03       Impact factor: 9.308

2.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

3.  Getting the price right: Medicare payment rates for cardiovascular services.

Authors:  Kevin J Hayes; Julian Pettengill; Jeffrey Stensland
Journal:  Health Aff (Millwood)       Date:  2007 Jan-Feb       Impact factor: 6.301

4.  Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001.

Authors:  F L Lucas; Michael A DeLorenzo; Andrea E Siewers; David E Wennberg
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

5.  Use of physicians' services under Medicare's resource-based payments.

Authors:  Stephanie Maxwell; Stephen Zuckerman; Robert A Berenson
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

6.  Acute coronary syndrome national statistics: challenges in definitions.

Authors:  Alain G Bertoni; Denise E Bonds; Thomas Thom; G John Chen; David C Goff
Journal:  Am Heart J       Date:  2005-06       Impact factor: 4.749

7.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Authors:  E M Antman; M J Tanasijevic; B Thompson; M Schactman; C H McCabe; C P Cannon; G A Fischer; A Y Fung; C Thompson; D Wybenga; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

  7 in total
  8 in total

1.  National trends in the prevalence and medical history of angina: 1988 to 2012.

Authors:  Julie C Will; Keming Yuan; Earl Ford
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05

2.  Geographic and racial patterns of preventable hospitalizations for hypertension: Medicare beneficiaries, 2004-2009.

Authors:  Julie C Will; Isaac A Nwaise; Linda Schieb; Yuna Zhong
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  The central role of comorbidity in predicting ambulatory care sensitive hospitalizations.

Authors:  Barry G Saver; Ching-Yun Wang; Sharon A Dobie; Pamela K Green; Laura-Mae Baldwin
Journal:  Eur J Public Health       Date:  2013-03-28       Impact factor: 3.367

4.  Acute coronary syndromes in the community.

Authors:  Sheila M Manemann; Yariv Gerber; Alanna M Chamberlain; Shannon M Dunlay; Malcolm R Bell; Allan S Jaffe; Susan A Weston; Jill M Killian; Jan Kors; Véronique L Roger
Journal:  Mayo Clin Proc       Date:  2015-03-18       Impact factor: 7.616

5.  National trends in visits to physician offices and outpatient clinics for angina 1995 to 2010.

Authors:  Julie C Will; Fleetwood Loustalot; Yuling Hong
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-01-14

6.  Preventable hospitalizations and emergency department visits for angina, United States, 1995-2010.

Authors:  Julie C Will; Amy L Valderrama; Paula W Yoon
Journal:  Prev Chronic Dis       Date:  2013-07-25       Impact factor: 2.830

7.  AHRQ prevention quality indicators to assess the quality of primary care of local providers: a pilot study from Italy.

Authors:  Lamberto Manzoli; Maria Elena Flacco; Corrado De Vito; Silvia Arcà; Flavia Carle; Lorenzo Capasso; Carolina Marzuillo; Angelo Muraglia; Fabio Samani; Paolo Villari
Journal:  Eur J Public Health       Date:  2013-12-23       Impact factor: 3.367

8.  Landscapes on Prevention Quality Indicators: A Spatial Analysis of Diabetes Preventable Hospitalizations in Portugal (2016-2017).

Authors:  Andre Ramalho; Mariana Lobo; Lia Duarte; Julio Souza; Paulo Santos; Alberto Freitas
Journal:  Int J Environ Res Public Health       Date:  2020-11-12       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.